Literature DB >> 6896549

Benzilylcholine mustard and spare receptors in guinea pig ileum.

H Siegel, D J Triggle.   

Abstract

A comparison was made of muscarinic receptor occupancy by the irreversible antagonist benzilylcholine mustard (BCM) as determined from shifts in the dose-response curve to a muscarinic agonist and from 3H-QNB binding to homogenates of BCM-treated tissue. Major discrepancies were found. A low concentration of BCM (3x10-8M/15 min.) produced a parallel dose-response curve shift corresponding to 98-99% receptor occupancy by BCM, whereas 3H-QNB binding revealed only 48% receptor occupancy. Possible origins of this discrepancy are discussed. High concentrations of BCM (5x10-5M, 15 min.) fail to completely alkylate all 3H-QNB binding sites even though response is completely lost. Although significant (64%) recovery of response occurs after prolonged tissue washing (240 min.) this is not accompanied by an increase in 3H-QNB binding. The small fraction (approximately 5%) of sites inaccessible to BCM and with reduced affinity for 3H-QNB may represent a subpopulation of muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896549     DOI: 10.1016/0024-3205(82)90497-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Affinity and efficacy correlate with chemical structure more than potency does in a series of pentatomic cyclic muscarinic agonists.

Authors:  P Angeli; L Brasili; M Giannella; F Gualtieri; M Pigini
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

2.  Comparison of the effects of some muscarinic agonists on smooth muscle function and phosphatidylinositol turnover in the guinea-pig taenia caeci.

Authors:  A L Gardner; L K Choo; F Mitchelson
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

3.  Characterization of the muscarinic receptor in human tracheal smooth muscle.

Authors:  C J van Koppen; J F Rodrigues de Miranda; A J Beld; M W Hermanussen; J W Lammers; C A van Ginneken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.